A Deeper Dive Into the Myocardium for the Detection of Cancer Therapy-Related Cardiac Dysfunction: Radiomics in Cardio-Oncology
This article relates to:
-
Clinical Study of Post-Chemotherapy Cardiotoxicity in Breast Cancer Patients Based on Ultrasound Radiomics
- Volume 42Issue 4Echocardiography
- First Published online: March 29, 2025
Corresponding Author
Edgar Francisco Carrizales-Sepúlveda
Heart Failure Unit, Cardiology Service, Hospital Universitario “Dr. José E. González”, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México
Search for more papers by this authorEduardo Hernández-Rangel
Multimodal Cardiac Imaging Laboratory, Cardiology Service, Hospital Universitario “Dr. José E. González”, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México
Search for more papers by this authorAlejandro Ordaz-Farías
Echocardiography Laboratory, Cardiology Service, Hospital Universitario “Dr. José E. González”, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México
Search for more papers by this authorCorresponding Author
Edgar Francisco Carrizales-Sepúlveda
Heart Failure Unit, Cardiology Service, Hospital Universitario “Dr. José E. González”, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México
Search for more papers by this authorEduardo Hernández-Rangel
Multimodal Cardiac Imaging Laboratory, Cardiology Service, Hospital Universitario “Dr. José E. González”, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México
Search for more papers by this authorAlejandro Ordaz-Farías
Echocardiography Laboratory, Cardiology Service, Hospital Universitario “Dr. José E. González”, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México
Search for more papers by this authorFunding: The authors received no specific funding for this work.
Conflicts of Interest
The authors declare no conflicts of interest.
References
- 1R. L. Siegel, A. N. Giaquinto, and A. Jemal, “Cancer Statistics, 2024,” CA: A Cancer Journal for Clinicians 74, no. 1 (2024): 12–49.
- 2D. P. Leong, S. Waliany, H. Abdel-Qadir, et al., “Cardiovascular Considerations during Cancer Therapy: Gaps in Evidence and JACC: CardioOncology Expert Panel Recommendations,” JACC CardioOncology 6, no. 6 (2024): 815–834.
- 3A. R. Lyon, T. López-Fernández, L. S. Couch, et al., “2022 ESC Guidelines on Cardio-Oncology Developed in Collaboration With the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS),” European Heart Journal 43, no. 41 (2022): 4229–4361.
- 4J. Herrmann, D. Lenihan, S. Armenian, et al., “Defining Cardiovascular Toxicities of Cancer Therapies: An International Cardio-Oncology Society (IC-OS) Consensus Statement,” European Heart Journal 43, no. 4 (2022): 280–299.
- 5C. Xia, S. Wu, Y. Zhong, J. Wang, A. Yao, and B. Liu, “Clinical Study of Post-Chemotherapy Cardiotoxicity in Breast Cancer Patients Based on Ultrasound Radiomics,” Echocardiography 42, no. 4 (2025): e70136.
- 6M. S. Maurer and M. Packer, “How Should Physicians Assess Myocardial Contraction?: Redefining Heart Failure with a Preserved Ejection Fraction,” JACC Cardiovascular Imaging 13, no. 3 (2020): 873–878.
- 7B. A. Borlaug, “Evaluation and Management of Heart Failure With Preserved Ejection Fraction,” Nature Reviews Cardiology 17, no. 9 (2020): 559–573.
- 8M. Christersson, S. Gustafsson, E. Lampa, et al., “Usefulness of Heart Failure Categories Based on Left Ventricular Ejection Fraction,” Journal of the American Heart Association 13, no. 8 (2024): e032257.
- 9M. Packer, “Left Ventricular Ejection Fraction in Heart Failure: Crazy, Stupid Love-and Maybe, Redemption,” Journal of the American Heart Association 13, no. 8 (2024): e034642.
- 10K. W. Reding, R. K. Cheng, A. Vasbinder, et al., “Lifestyle and Cardiovascular Risk Factors Associated With Heart Failure Subtypes in Postmenopausal Breast Cancer Survivors,” JACC: CardioOncology 4, no. 1 (2022): 53–65.
- 11T. H. Marwick, R. L. Leano, J. Brown, et al., “Myocardial Strain Measurement With 2-Dimensional Speckle-Tracking Echocardiography: Definition of Normal Range,” JACC Cardiovascular Imaging 2, no. 1 (2009): 80–84.
- 12E. K. Oikonomou, D. G. Kokkinidis, P. N. Kampaktsis, et al., “Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis,” JAMA Cardiology 4, no. 10 (2019): 1007–1018.
- 13T. Negishi, P. Thavendiranathan, M. Penicka, et al., “Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy: 3-Year Results of the SUCCOUR Trial,” JACC Cardiovascular Imaging 16, no. 3 (2023): 269–278.
- 14Q. A. Hathaway, Y. Abdeen, J. Conte, et al., “Prediction of Heart Failure and All-Cause Mortality Using Cardiac Ultrasomics in Patients With Breast Cancer,” International Journal of Cardiovascular Imaging 40, no. 6 (2024): 1305–1317.
- 15N. Kagiyama, S. Shrestha, J. S. Cho, et al., “A Low-Cost Texture-Based Pipeline for Predicting Myocardial Tissue Remodeling and Fibrosis Using Cardiac Ultrasound,” EBioMedicine 54 (2020): 102726.
